The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors |
|
|
2. | Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver Transplantation. |
|
Am J Gastroenterol.2024 Jul 25;120(2):459-468.doi:10.14309/ajg.0000000000002977 |
|
Aziz, Bishoi (B);Kok, Beverley (B);Cheah, Matthew (M);Lytvyak, Ellina (E);Moctezuma-Velazquez, Carlos (C);Wasilenko, Shawn (S);Tsochatzis, Emmanuel (E);Ravikumar, Reena (R);Jose, Sophie (S);Allison, Michael (M);Gunson, Bridget (B);Manas, Derek (D);Monaco, Andrea (A);Mirza, Darius (D);Fusai, Giuseppe (G);Owen, Nicola (N);Thorburn, Douglas (D);Roberts, Keith (K);Srinivasan, Parthi (P);Wigmore, Stephen (S);Athale, Anuja (A);Creamer, Felicity (F);Fernando, Bimbi (B);Iyer, Vikram (V);Madanur, Mansoor (M);Sen, Gourab (G);Montano-Loza, Aldo J (AJ);Hansen, Bettina (B);Mason, Andrew L (AL); |
|
|
3. | Inhibition of RAC1 activator DOCK2 ameliorates cholestatic liver injury via regulating macrophage polarisation and hepatic stellate cell activation. |
|
Biol Direct.2025 Feb 08;20(1):21.doi:10.1186/s13062-025-00612-3 |
|
Qiu, Jianli (J);Qu, Yitong (Y);Li, Yinli (Y);Li, Cancan (C);Wang, Junling (J);Meng, Lu (L);Jing, Xiaojin (X);Fu, Jiangping (J);Xu, Yan (Y);Chai, Yuna (Y); |
|
|
|
|
5. | Effect of Daily Fiber Intake Among Cirrhotic Patients With and Without Portosystemic Shunts. |
|
Curr Dev Nutr.2024 Dec 15;9(1):104527.doi:10.1016/j.cdnut.2024.104527 |
|
Parisse, Simona (S);Carnevale, Sara (S);Damato, Elio (E);Ferri, Flaminia (F);Mischitelli, Monica (M);Corona, Mario (M);Lucatelli, Pierleone (P);Cantafora, Alfredo (A);De Santis, Adriano (A);Alvaro, Domenico (D);Muscaritoli, Maurizio (M);Ginanni Corradini, Stefano (S); |
|
|
6. | Multiomic Sequencing Reveals Distinctive Gene Expression and Epigenetic Alterations Associated With Primary Sclerosing Cholangitis Development in Treatment-Naïve Pediatric Ulcerative Colitis. |
|
Gastro Hep Adv.2024 Nov 16;4(3):100586.doi:10.1016/j.gastha.2024.11.002 |
|
Rodriguez-Sosa, Alejandra (A);Lawal, Ololade (O);McDonnell, Ciaran (C);Grant, Luke (L);O'Brien, John (J);Ali, Muhammad (M);Stephens, Ian (I);Kirwan, Grainne (G);Genua, Flavia (F);Kel, Alexander (A);Dominik, Anna (A);Stack, Roisin (R);Yochum, Gregory (G);McDermot, Michael (M);Doherty, Glen (G);Hussey, Seamus (S);Das, Sudipto (S); |
|
|
|
|
|
|
|
|
|
|
11. | Serum amyloid P (PTX2) attenuates hepatic fibrosis in mice by inhibiting the activation of fibrocytes and HSCs. |
|
|
|
Cong, Min (M);Carvalho Gontijo Weber, Raquel (R);Sakane, Sadatsugu (S);Zhang, Vivian (V);Jiang, Chunyan (C);Taura, Kojiro (K);Kodama, Yuzo (Y);DeMinicis, Samuele (S);Ganguly, Souradipta (S);Brafman, David (D);Chien, Shu (S);Kramer, Michael (M);Lupher, Mark (M);Brenner, David A (DA);Xu, Jun (J);Kisseleva, Tatiana (T); |
|
|
12. | Association of gut microbiota and gut metabolites and adverse outcomes in biliary atresia: A longitudinal prospective study. |
|
|
|
Jain, Vandana (V);Dalby, Matthew J (MJ);Alexander, Emma C (EC);Burford, Charlotte (C);Acford-Palmer, Holly (H);Serghiou, Iliana R (IR);Teng, Nancy M Y (NMY);Kiu, Raymond (R);Gerasimidis, Konstantinos (K);Zafeiropoulou, Konstantina (K);Logan, Michael (M);Verma, Anita (A);Davenport, Mark (M);Hall, Lindsay J (LJ);Dhawan, Anil (A); |
|
|
|
|
|
|
15. | Efficacy and Safety of Ileal Bile Acid Transport Inhibitors in Inherited Cholestatic Liver Disorders: A Meta-analysis of Randomized Controlled Trials. |
|
|
|
Imran, Muhammad (M);Elsnhory, Ahmed B (AB);Ibrahim, Ahmed A (AA);Elnaggar, Mohamed (M);Tariq, Muhammad S (MS);Mehmood, Areeba M (AM);Ali, Shujaat (S);Khalil, Saba (S);Khan, Sheharyar H (SH);Ali, Mansab (M);Abuelazm, Mohamed (M); |
|
|
16. | Hepatotoxicity of statins: a real-world study based on the US Food and Drug Administration Adverse Event Reporting System database. |
|
|
|
Wang, Bojing (B);Huang, Shu (S);Li, Shiqi (S);Deng, Yaqi (Y);Li, Ziyan (Z);Wang, Yizhou (Y);Shi, Xiaomin (X);Zhang, Wei (W);Shi, Lei (L);Wang, Xiaohong (X);Tang, Xiaowei (X); |
|
|
|
|
18. | Real-world experience with odevixibat in children with progressive familial intrahepatic cholestasis. |
|
|
|
Di Giorgio, Angelo (A);Sciveres, Marco (M);Fuoti, Maurizio (M);Calvo, PierLuigi (P);Cananzi, Mara (M);Lleo, Ana (A);Gatti, Simona (S);Indolfi, Giuseppe (G);Madeo, Annalisa (A);Mandato, Claudia (C);Nuti, Federica (F);Zanchi, Chiara (C);Carioli, Greta (G);Ghirardi, Arianna (A);Nicastro, Emanuele (E);D'Antiga, Lorenzo (L); |
|
|
19. | Pruritus in primary biliary cholangitis is under-recorded in patient medical records. |
|
|
|
Gungabissoon, Usha (U);Smith, Helen T (HT);von Maltzahn, Robyn (R);Logie, John (J);Fairburn-Beech, Jolyon (J);Ma, Liyuan (L);P, Dhirishiya (D);McGirr, Ashleigh (A);Hunnicutt, Jake N (JN);Rowe, Christopher L (CL);Tierney, Meghan (M);Friedler, Haley S (HS); |
|
|
|
|
21. | Chronic Pruritus: A Review. |
|
|
|
Butler, Daniel C (DC);Berger, Timothy (T);Elmariah, Sarina (S);Kim, Brian (B);Chisolm, Sarah (S);Kwatra, Shawn G (SG);Mollanazar, Nicholas (N);Yosipovitch, Gil (G); |
|
|
22. | Relationship between pruritus and sleep in participants with primary biliary cholangitis in the Phase 2b GLIMMER trial. |
|
|
|
von Maltzahn, Robyn (R);Mayo, Marlyn J (MJ);Smith, Helen T (HT);Thompson, April (A);Das, Sugato (S);de Souza, Andrea Ribeiro (AR);Lisi, Edoardo (E);Levy, Cynthia (C);McLaughlin, Megan M (MM);Jones, David (D); |
|
|
|
|
|
|
25. | Dose-related effects of intraduodenal quinine on plasma glucose, glucoregulatory hormones and gastric emptying of a nutrient drink, and energy intake, in men with type 2 diabetes: a double-blind, randomised, crossover study. |
|
|
|
Bitarafan, Vida (V);Anjom-Shoae, Javad (J);Rezaie, Peyman (P);Fitzgerald, Penelope C E (PCE);Lange, Kylie (K);Horowitz, Michael (M);Feinle-Bisset, Christine (C); |
|
|
|
|
|
|
|
|
29. | Deep learning helps discriminate between autoimmune hepatitis and primary biliary cholangitis. |
|
|
|
Gerussi, Alessio (A);Saldanha, Oliver Lester (OL);Cazzaniga, Giorgio (G);Verda, Damiano (D);Carrero, Zunamys I (ZI);Engel, Bastian (B);Taubert, Richard (R);Bolis, Francesca (F);Cristoferi, Laura (L);Malinverno, Federica (F);Colapietro, Francesca (F);Akpinar, Reha (R);Di Tommaso, Luca (L);Terracciano, Luigi (L);Lleo, Ana (A);Viganó, Mauro (M);Rigamonti, Cristina (C);Cabibi, Daniela (D);Calvaruso, Vincenza (V);Gibilisco, Fabio (F);Caldonazzi, Nicoló (N);Valentino, Alessandro (A);Ceola, Stefano (S);Canini, Valentina (V);Nofit, Eugenia (E);Muselli, Marco (M);Calderaro, Julien (J);Tiniakos, Dina (D);L'Imperio, Vincenzo (V);Pagni, Fabio (F);Zucchini, Nicola (N);Invernizzi, Pietro (P);Carbone, Marco (M);Kather, Jakob Nikolas (JN); |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
38. | Perihilar and Intrahepatic Cholangiocarcinoma after Resection: Clinicopathological Characteristics, Outcomes, and Implications for Addition of Chemoradiotherapy. |
|
|
|
Sahai, Puja (P);Rastogi, Archana (A);Gupta, Ajay (A);Patil, Nilesh S (NS);Sharma, Namita (N);Mohapatra, Nihar (N);Sharma, Archana (A);Rudrakumar, Karthika (K);Jindal, Ankur (A);Mukund, Amar (A);Kumar, Guresh (G);Pamecha, Viniyendra (V);Yadav, Hanuman P (HP); |
|
|
|
|
40. | Primary sclerosing cholangitis-inflammatory bowel disease: Epidemiology, mortality, and impact of diagnostic sequence. |
|
|
|
Leung, Kristel K (KK);Li, Wenbin (W);Hansen, Bettina (B);Gulamhusein, Aliya (A);Lapointe-Shaw, Lauren (L);Shaheen, Abdel Aziz (AA);Ricciuto, Amanda (A);Benchimol, Eric I (EI);Flemming, Jennifer A (JA);Hirschfield, Gideon M (GM); |
|
|
|
|
|
|
|
|
44. | Integrated molecular characterization reveals the pathogenesis and therapeutic strategies of pulmonary blastoma. |
|
|
|
Tian, He (H);Yang, Zhenlin (Z);Yang, Junhui (J);Chen, Ying (Y);Li, Lin (L);Fan, Tao (T);Liu, Tiejun (T);Bai, Guangyu (G);Gao, Yibo (Y);He, Jie (J); |
|
|
|
|
|
|
|
|
|
|
|
|